P13 BABRAHAM

From LipidomicsWiki

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
|myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through  association with Birmingham University access to human samples and
|myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through  association with Birmingham University access to human samples and
DNA array facilities.
DNA array facilities.
-
|myTaskforces=
+
|myTaskforces=[[Task_Force_I|Task Force I]], [[Task_Force_II|Task Force II]], [[Task_Force_VI|Task Force VI]], [[Task_Force_VII|Task Force VII]], and [[Task_Force_IX|Task Force IX]]
-
|myWorkpackages=
+
|myWorkpackages=[[WP4|WP4]]
}}<br> <br>  
}}<br> <br>  
[[Category:Project_organisation]]
[[Category:Project_organisation]]

Revision as of 12:41, 17 June 2011

InstitutionThe Babraham Institute, Cambridge - Michael Wakelam
Principal investigator {{{myPrincipal_investigator}}}
Country United Kingdoms
Beneficiary NumberP13
About us
ContributionsThe Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through association with Birmingham University access to human samples and DNA array facilities.
Member of TaskforcesTask Force I, Task Force II, Task Force VI, Task Force VII, and Task Force IX
Member of WorkpackagesWP4

Back to List of Beneficiaries




Personal tools
Create a book